Stocks teetered between small losses and gains through the morning session as a selloff in healthcare offset gains in retail. Healthcare was under pressure ahead of an expected revised repeal-and-replace bill from the Senate GOP. Upbeat guidance from Target Corp. (TGT) inspired a rally in the retail sector. Target anticipates a "modest increase" in same-store sales over the quarter, far better than analyst consensus of a decline. The company saw improvement in traffic and category sales trends. Delta (DAL) declined after falling short of profit estimates in its second quarter. By region, domestic and Latin America revenue rose, while Atlantic and Pacific sales declined. Snap Inc. (SNAP) increased after Stifel upgraded its rating to BUY. The firm is optimistic over the company's user engagement and overall growth and says recent selloffs could be an overreaction to a lock-up expiration.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.